Our Locations

The Shanghai headquarter was established in 2006. By the end of June 2023, the R&D center has expanded to more than 32,000 square meters. Professional team dedicated to the process development of small molecule, payloads, linkers and oligonucleotide, analytical chemistry laboratories and QC/QA. With the support of a vast building block library, we have served global clients with process development and manufacturing of APIs and advanced intermediates from exploratory medicinal chemistry research, drug discovery and preclinical development, clinical development to commercialization.

The Shanghai R&D Center focuses on the API CMC service and formulation CMC service. The R&D and GMP kilo lab facilities is about 4,500 square meters. It has passed one EU 3rd party QP on site GMP audit for early clinical stage API.

Anhui Ma’anshan R&D Center has a GMP kilogram laboratory for the production of Potency API and Cytotoxins, linker-toxins for antibody-drug conjutes. The total volume of the reactors is about 4,000 L.

The Anhui c-GMP manufacturing site covers an area of about 87,860 square meters. At present, it has more than 120 reactors with a total volume of about 320,000L.

The GMP formulation and drug product manufacturing facility in Jiangsu has over 13,000 square meters, with 7 independent Class D clean workshops. 4 workshops for solid form oral medicines have a total annual production capacity of about 1 billion units. The 2 semi-solid topical formulation workshops has a capacity of about 40 million tubes annually. 1 Solid dispersion line (a large scale topical preparation line).

Total area: 39,000 ft²
Reactors: 45, range from 500L - 5,000L, Scale up to hundreds of kgs per batch
Total volume: ~115,500L

The total area is approximately 40,000 square feet. For Protein-related Drug Substance (DS), there are multiple production scales available at 200L, 500L, and 2000L. Additionally, there is 1 Drug Product (DP) filling line, 1 Lyophilization production line, and 1 Conjugation production line (200L).